John E. (Jack) Bailey Jr., President and CEO at G1 Therapeutics, Inc. (GTHX), sold 68,250 shares at $10.41 ($710K) on 2022-01-03, disclosed to the SEC on 2022-01-05.
Open-market sale of $710k GTHX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.41 | 34,125 | $355K | 50.0% |
| 2 | $10.41 | 34,125 | $355K | 50.0% |
| Total | $10.41 avg | 68,250 | $710K | 100% |
| Filing → |
| GTHX | SELL | 2024-01-08 | $36K | — | Filing → |
| GTHX | SELL | 2024-01-02 | $216K | — | Filing → |
| GTHX | SELL | 2023-07-07 | $7K | — | Filing → |